Stay updated on Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page
- Check3 days agoChange DetectedA new revision entry, Revision: v3.6.2, has been added to the Study Record History, replacing Revision: v3.6.0. This indicates a minor platform update to the history view.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe study page now shows that recruitment has ceased. The page revision is updated to v3.6.0, replacing the previous version.SummaryDifference0.1%

- Check24 days agoChange DetectedA new revision entry v3.5.5 was added to the record history, and the previous v3.5.4 entry was removed. This update represents an administrative adjustment to the study's revision history.SummaryDifference0.0%

- Check46 days agoChange DetectedA new site revision entry, Revision: v3.5.4, was added to the history, superseding the previous Revision: v3.5.3.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page’s displayed ClinicalTrials.gov revision/version number has been updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check74 days agoChange DetectedAdded revision v3.5.2 to the history and removed revision v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page.